Showing results (131-140 of 177) with videos related to
Sort By:
Pageof 18
HNO|February 3, 2023
Future therapeutic strategies for olfactory disorders: electrical stimulation, stem cell therapy, and transplantation of olfactory epithelium-an overviewN Gunder, P Dörig, M Witt, et al.Nanotechnology|March 2, 2017
SET kinetics of electrochemical metallization cells: influence of counter-electrodes in SiO2/Ag based systemsM Lübben, S Menzel, S G Park, et al.British Journal of Haematology|June 1, 1985
A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease?J S Wainscoat, S L Thein, D R Higgs, et al.British Journal of Haematology|July 1, 1991
Novel point mutations leading to type 1 antithrombin deficiency and thrombosisR J Olds, D A Lane, H Ireland, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 31, 1988
Genetic factors as determinants of infectious disease transmission in human communitiesD J Weatherall, J I Bell, J B Clegg, et al.British Journal of Cancer|April 1, 1987
Detection of somatic changes in human cancer DNA by DNA fingerprint analysisS L Thein, A J Jeffreys, H C Gooi, et al.British Journal of Haematology|March 1, 1995
Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): two novel antithrombin variants with abnormal heparin bindingV Chowdhury, B Mille, R J Olds, et al.The Journal of Biological Chemistry|June 15, 1989
A novel amino acid substitution in the reactive site of a congenital variant antithrombin. Antithrombin pescara, ARG393 to pro, caused by a CGT to CCT mutationD A Lane, H Erdjument, E Thompson, et al.British Journal of Haematology|May 1, 1987
Thalassaemia intermedia: interaction of the triple alpha-globin gene arrangement and heterozygous beta-thalassaemiaA E Kulozik, S L Thein, J S Wainscoat, et al.Blood|December 23, 1999
Genetic influences on F cells and other hematologic variables: a twin heritability studyC Garner, T Tatu, J E Reittie, et al.Pageof 18